XML 14 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2024 $ 211,881 $ 7 $ 441,727 $ 23 $ (229,876)
Beginning balance, shares at Dec. 31, 2024   67,255,434      
Vesting of restricted stock units   320,333      
Stock-based compensation expense 2,022   2,022    
Unrealized gain (loss) on marketable securities 263     263  
Net Income (Loss) (20,781)       (20,781)
Ending balance at Mar. 31, 2025 193,385 $ 7 443,749 286 (250,657)
Ending balance, shares at Mar. 31, 2025   67,575,767      
Beginning balance at Dec. 31, 2024 211,881 $ 7 441,727 23 (229,876)
Beginning balance, shares at Dec. 31, 2024   67,255,434      
Unrealized gain (loss) on marketable securities 295        
Net Income (Loss) (29,447)        
Ending balance at Jun. 30, 2025 185,764 $ 7 444,762 318 (259,323)
Ending balance, shares at Jun. 30, 2025   67,764,100      
Beginning balance at Mar. 31, 2025 193,385 $ 7 443,749 286 (250,657)
Beginning balance, shares at Mar. 31, 2025   67,575,767      
Vesting of restricted stock units   188,333      
Stock-based compensation expense 1,013   1,013    
Unrealized gain (loss) on marketable securities 32     32  
Net Income (Loss) (8,666)       (8,666)
Ending balance at Jun. 30, 2025 185,764 $ 7 444,762 318 (259,323)
Ending balance, shares at Jun. 30, 2025   67,764,100      
Beginning balance at Dec. 31, 2025 160,475 $ 5 449,762 435 (289,727)
Beginning balance, shares at Dec. 31, 2025   47,766,338      
Vesting of restricted stock units   563      
Issuance of common stock upon exercise of stock options 5   5    
Issuance of common stock upon exercise of stock options, Share   1,642      
Stock-based compensation expense 1,605   1,605    
Unrealized gain (loss) on marketable securities (278)     (278)  
Net Income (Loss) (13,722)       (13,722)
Ending balance at Mar. 31, 2026 148,085 $ 5 451,372 157 (303,449)
Ending balance, shares at Mar. 31, 2026   47,768,543      
Beginning balance at Dec. 31, 2025 $ 160,475 $ 5 449,762 435 (289,727)
Beginning balance, shares at Dec. 31, 2025   47,766,338      
Issuance of common stock upon exercise of stock options, Share 97,720        
Unrealized gain (loss) on marketable securities $ (502)        
Net Income (Loss) (27,220)        
Ending balance at Jun. 30, 2026 239,547 $ 6 556,555 (67) (316,947)
Ending balance, shares at Jun. 30, 2026   57,436,255      
Beginning balance at Mar. 31, 2026 148,085 $ 5 451,372 157 (303,449)
Beginning balance, shares at Mar. 31, 2026   47,768,543      
Vesting of restricted stock units   70,275      
Issuance of common stock upon exercise of stock options 255   255    
Issuance of common stock upon exercise of stock options, Share   96,078      
Issuance of common stock and pre-funded warrants in private placement, net of issuance costs, Share   9,481,000      
Issuance of common stock and pre-funded warrants in private placement, net of issuance costs, Value 103,369 $ 1 103,368    
Issuance of common stock under equity incentive plans related to ESPP 79   79    
Issuance of common stock under equity incentive plans related to ESPP, Share   20,359      
Stock-based compensation expense 1,481   1,481    
Unrealized gain (loss) on marketable securities (224)     (224)  
Net Income (Loss) (13,498)       (13,498)
Ending balance at Jun. 30, 2026 $ 239,547 $ 6 $ 556,555 $ (67) $ (316,947)
Ending balance, shares at Jun. 30, 2026   57,436,255